The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares



Results

Search articles by EPIC code
ARTICLE

Venn Life Sciences – shares restored at a massive premium… but much more to come

2019-06-13 08:30:24

Drug development & clinical trial services company Venn Life Sciences (VENN) has announced audited 2018 results, a placing and acquisition (in which Tom Winnifrith has shares) progress which has seen the shares restored to trading – and we have chatted with CEO Cathal Friel…

ARTICLE

Venn Life Sciences – transformative acquisition

2019-05-14 09:00:00

Venn Life Sciences (VENN) has served up 2018 results which, predictably, were a bit of a kitchen sink affair. But that is not the real news. This is the RTO of Open Orphan, which will be transformational. Ahead of that the shares will be suspended...

NEWSFLOW ARTICLE

Venn Life Sciences – loan note issued. Hold tight, fireworks on the way

2019-04-12 08:16:00

Venn Life Sciences (VENN), the AIM-listed integrated drug development partner, has announced that Raglan Capital, the vehicle of Cathal Friel, has subscribed for loan notes of £250,000...

ARTICLE

Venn Life Sciences - a buy

2019-02-05 03:11:00

A tip last month on HotStockRockets - the shares are already comfortably ahead on the tip price, but there looks much more to come...

NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW NEWSFLOW

Search ShareProphets |

Recent Comments |




About ShareProphets

Contact Us

Advertise With Us

Send Us A Tip

Donate


Terms of Service

Privacy Policy

Cookie Policy


Forgot My Password

Forgot My Username

Resend Account Validation Token

Site by Everywhen